Together, these P450 enzymes metabolize multiple drugs, and alteration in their enzyme activity or expression could modulate the biotransformation of several drugs in T2DM patients, thus making them either toxic or ineffective (prodrugs). This evidence concerns the gene CYP2B6 and type 2 diabetes mellitus.